Global Sevoflurane (Sevoflurane Source) Sales Market Report 2022

Sevoflurane is a halogenated general inhalation anesthetic drug.
Market Analysis and Insights: Global Sevoflurane (Sevoflurane Source) Market
Due to the COVID-19 pandemic, the global Sevoflurane (Sevoflurane Source) market size is estimated to be worth US$ 1322.6 million in 2021 and is forecast to a readjusted size of US$ 1322.6 million by 2028 with a CAGR of -0.5% during the review period. Fully considering the economic change by this health crisis, by Type accounting for % of the Sevoflurane (Sevoflurane Source) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Type segment is altered to an % CAGR throughout this forecast period.
The top 5 players was expected to reach at about 65% market share by 2020, in terms of the globle sevoflurane revenue.
Global Sevoflurane (Sevoflurane Source) Scope and Market Size
The global Sevoflurane (Sevoflurane Source) market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Sevoflurane (Sevoflurane Source) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
Segment by Type
Original Drugs
Generic Drugs
Segment by Application
For Human
For Animal
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Abbott(AbbVie)
Baxter
Maruishi Pharmaceutical
Jiangsu Hengrui
Lunan

Frequently Asked Questions